Headlands Technologies »

Akero Therapeutics shares owned by Headlands Technologies

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Headlands Technologies from 13F filings

Historical chart of Headlands Technologies investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Headlands Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Headlands Technologies

Quarter filed Position value Share count Share price at filing
2024-03-31 $107k 4.2k 25.26
2023-12-31 $28k 1.2k 23.35

More positions owned by Headlands Technologies

NVIDIA Corporation (NVDA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
Microsoft Corporation (MSFT)
Linde SHS (LIN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vale S A Sponsored Ads (VALE)
Asml Holding N V N Y Registry Shs (ASML)
Rio Tinto Sponsored Adr (RIO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Applied Materials (AMAT)
Petroleo Brasileiro Sa Petro Sponsored Adr (PBR)
Broadcom (AVGO)
At&t (T)
Verisign (VRSN)

View all positions for Headlands Technologies

Top funds holding Akero Therapeutics

Henderson Group
T. Rowe Price Associates
Vanguard Group
Wellington Management Company
Baker Bros. Advisors
Yiheng Capital
Boxer Capital
Alliancebernstein
Redmile Group
Perceptive Advisors
Logos Global Management
Point72 Asset Management
Citadel Advisors
Goldman Sachs Group
Holocene Advisors

View all funds holding Akero Therapeutics